{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:55:33Z","timestamp":1777413333054,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1999,7,30]],"date-time":"1999-07-30T00:00:00Z","timestamp":933292800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1038\/sj.bjc.6690620","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:08:39Z","timestamp":1031249319000},"page":"1912-1919","source":"Crossref","is-referenced-by-count":100,"title":["A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts"],"prefix":"10.1038","volume":"80","author":[{"given":"G","family":"Pratesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Perego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Polizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S C","family":"Righetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Supino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Caserini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Manzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F C","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Pezzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Tognella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Zunino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,7,30]]},"reference":[{"key":"BF6690620_CR1","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1073\/pnas.93.9.4091","volume":"93","author":"RK Brachmann","year":"1996","unstructured":"Brachmann, R. K., Vidal, M. & Boeke, J. D. (1996). Dominant-negative p53 mutations selected in yeast hit cancer hot spots. Proc Natl Acad Sci USA 93: 4091\u20134095.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690620_CR2","first-page":"955","volume":"3","author":"C Caserini","year":"1997","unstructured":"Caserini, C., Pratesi, G., Tortoreto, M., Bedogn\u00e9, B., Carenini, N., Supino, R., Perego, P., Righetti, S. C. & Zunino, F. (1997). Apoptosis as a determinant of tumour sensitivity to topotecan in human ovarian tumours: preclinical in vitro\/in vivo studies. Clin Cancer Res 3: 955\u2013961.","journal-title":"Clin Cancer Res"},{"key":"BF6690620_CR3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0021-9258(17)42175-2","volume":"269","author":"G Chu","year":"1994","unstructured":"Chu, G. (1994). Cellular responses to cisplatin. J Biol Chem 269: 787\u2013790.","journal-title":"J Biol Chem"},{"key":"BF6690620_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0305-7372(97)90032-3","volume":"23","author":"M Crul","year":"1997","unstructured":"Crul, M., Schellens, J. H. M., Beijnen, J. H. & Maliepaard, M. (1997). Cisplatin resistance and DNA repair. Cancer Treat Rev 23: 341\u2013366.","journal-title":"Cancer Treat Rev"},{"key":"BF6690620_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0163-7258(87)90009-X","volume":"34","author":"A Eastman","year":"1987","unstructured":"Eastman, A. (1987). The information, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther 34: 155\u2013166.","journal-title":"Pharmacol Ther"},{"key":"BF6690620_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3109\/07357909309011676","volume":"11","author":"N Farrell","year":"1993","unstructured":"Farrell, N. (1993). Nonclassical platinum antitumour agents: perspective for design and development of new drugs complementary to cisplatin. Cancer Invest 11: 578\u2013589.","journal-title":"Cancer Invest"},{"key":"BF6690620_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/02603599508035777","volume":"16","author":"N Farrell","year":"1995","unstructured":"Farrell, N. (1995a). DNA binding and chemistry of dinuclear platinum complexes. Comments in Inorganic Chemistry 16: 373\u2013389.","journal-title":"Comments in Inorganic Chemistry"},{"key":"BF6690620_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1067-568X(96)80010-7","volume-title":"Advances in DNA Sequence Specific Agents","author":"N Farrell","year":"1996","unstructured":"Farrell, N. (1996). DNA binding of dinuclear platinum complexes. In Advances in DNA Sequence Specific Agents, Hurley LH, Chaires JB JAI Press Inc 187\u2013216."},{"key":"BF6690620_CR9","doi-asserted-by":"publisher","first-page":"15480","DOI":"10.1021\/bi00047a013","volume":"34","author":"N Farrell","year":"1995","unstructured":"Farrell, N., Appleton, T. G., Qu, Y., Roberts, J. D., Soares Fontes, A. P., Skov, K. A., Wu, P. & Zou, Y. (1995b). Effects of geometric isomerism and ligand substitution in bifunctional dinuclear platinum complexes on binding properties and conformational changes in DNA. Biochemistry 34: 15480\u201315487.","journal-title":"Biochemistry"},{"key":"BF6690620_CR10","first-page":"310","volume":"38","author":"N Farrell","year":"1997","unstructured":"Farrell, N., Qu, Y., Kasparkova, J., Brabec, V., Valsecchi, M., Menta, E., Di Domenico, R., Conti, M., Da Re, G., Lotto, A. & Spinelli, S. (1997). Chemical studies and DNA binding of charged polynuclear platinum complexes. Proc Am Ass Cancer Res 38: 310","journal-title":"Proc Am Ass Cancer Res"},{"key":"BF6690620_CR11","first-page":"4881","volume":"56","author":"D Fink","year":"1996","unstructured":"Fink, D., Nebel, S., Aebi, S., Zheng, H., Cenni, B., Nehm\u00e9, A., Christen, R. D. & Howell, S. B. (1996). The role of DNA mismatch repair in platinum drug resistance. Cancer Res 56: 4881\u20134886.","journal-title":"Cancer Res"},{"key":"BF6690620_CR12","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/jnci\/88.20.1442","volume":"88","author":"CC Harris","year":"1996","unstructured":"Harris, C. C. (1996). Structure and function of the p53 tumour suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442\u20131455.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690620_CR13","first-page":"953","volume":"12","author":"D Hecker","year":"1996","unstructured":"Hecker, D., Page, G., Lohrum, M., Weiland, S. & Scheidtmann, K. H. (1996). Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs. Oncogene 12: 953\u2013961.","journal-title":"Oncogene"},{"key":"BF6690620_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0959-8049(96)00080-9","volume":"32A","author":"JA Hickman","year":"1996","unstructured":"Hickman, J. A. (1996). Apoptosis and chemotherapy resistance. Eur J Cancer 32A: 921\u2013926.","journal-title":"Eur J Cancer"},{"key":"BF6690620_CR15","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/nar\/20.7.1697","volume":"20","author":"A Johnson","year":"1992","unstructured":"Johnson, A., Qu, Y., Van Houten, B. & Farrell, N. (1992). B\u2192Z-DNA conformational changes induced by a family of bis(platinum) complexes. Nucleic Acids Res 20: 1697\u20131703.","journal-title":"Nucleic Acids Res"},{"key":"BF6690620_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00690207","volume":"14","author":"MB Kastan","year":"1995","unstructured":"Kastan, M. B., Canman, C. E. & Leonard, C. J. (1995). P53, cell cycle and apoptosis implications for cancer. Cancer Met Rev 14: 3\u201315.","journal-title":"Cancer Met Rev"},{"key":"BF6690620_CR17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0959-8049(94)90281-X","volume":"30A","author":"LR Kelland","year":"1994","unstructured":"Kelland, L. R. (1994). The molecular basis of cisplatin sensitivity\/resistance. Eur J Cancer 30A: 725\u2013727.","journal-title":"Eur J Cancer"},{"key":"BF6690620_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.7973635","volume":"266","author":"SW Lowe","year":"1994","unstructured":"Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E. & Jacks, T. (1994). p53 status and the efficacy of cancer therapy in vivo. Science 266: 807\u2013810.","journal-title":"Science"},{"key":"BF6690620_CR19","first-page":"4285","volume":"57","author":"PM O\u2019Connor","year":"1997","unstructured":"O\u2019Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., Friend, S., Fornace, A. J. & Kohn, K. W. (1997). Characterization of the p53 tumour suppressor pathway in cell lines of the National Cancer Institute Anticancer Drug Screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 57: 4285\u20134300.","journal-title":"Cancer Res"},{"key":"BF6690620_CR20","first-page":"556","volume":"56","author":"P Perego","year":"1996","unstructured":"Perego, P., Giarola, M., Righetti, S. C., Supino, R., Caserini, C., Delia, D., Pierotti, M. A., Miyashita, T., Reed, J. C. & Zunino, F. (1996). Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res 56: 556\u2013562.","journal-title":"Cancer Res"},{"key":"BF6690620_CR21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1023\/A:1026442716000","volume":"2","author":"P Perego","year":"1997","unstructured":"Perego, P., Righetti, S. C., Supino, R., Delia, D., Caserini, C., Carenini, N., Bedogne\u2019, B., Broome, E., Krajewski, S., Reed, J. C. & Zunino, F. (1997). Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines. Apoptosis 2: 540\u2013548.","journal-title":"Apoptosis"},{"key":"BF6690620_CR22","first-page":"528","volume":"5","author":"P Perego","year":"1999","unstructured":"Perego, P., Caserini, C., Gatti, L., Carenini, N., Romanelli, S., Supino, R., Colangelo, D., Viano, I., Leone, R., Spinelli, S., Pezzoni, G., Manzotti, C., Farrell, N. & Zunino, F. (1999). A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system. Mol. Pharmacol 5: 528\u2013534.","journal-title":"Mol. Pharmacol"},{"key":"BF6690620_CR23","first-page":"689","volume":"56","author":"SC Righetti","year":"1996","unstructured":"Righetti, S. C., Della Torre, G., Pilotti, S., Menard, S., Ottone, F., Colnaghi, M. I., Pierotti, M. A., Lavarino, C., Cornarotti, M., Oriana, S., Bohm, S., Bresciani, G. L., Spatti, G. & Zunino, F. (1996). A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Cancer Res 56: 689\u2013693.","journal-title":"Cancer Res"},{"key":"BF6690620_CR24","first-page":"763","volume":"11","author":"N Rolley","year":"1995","unstructured":"Rolley, N., Butcher, S. & Milner, J. (1995). Specific DNA binding by different classes of human p53 mutants. Oncogene 11: 763\u2013770.","journal-title":"Oncogene"},{"key":"BF6690620_CR25","first-page":"253","volume":"3","author":"R Supino","year":"1996","unstructured":"Supino, R., Righetti, S. C., Magnani, I., Bottiroli, G. & Prosperi, E. (1996). Modulation and cell cycle distribution of mutant p53 protein in a human small-cell lung carcinoma cell line after exposure to cytotoxic agents. Cell Pharmacol 3: 253\u2013260.","journal-title":"Cell Pharmacol"},{"key":"BF6690620_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/370174a0","volume":"370","author":"B Vogelstein","year":"1994","unstructured":"Vogelstein, B. & Kinzler, K. W. (1994). X-rays strike p53 again. Nature 370: 174\u2013175.","journal-title":"Nature"},{"key":"BF6690620_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ng0695-188","volume":"10","author":"XW Wang","year":"1995","unstructured":"Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J-M, Wang, Z., Freidberg, E. C., Evans, M. K., Taff, B. G., Bohr, V. A., Weeda, G., Hoeijmakers, J. H. J., Forrester, K. & Harris, C. C. (1995). p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet 10: 188\u2013195.","journal-title":"Nat Genet"},{"key":"BF6690620_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/bjc.1988.174","volume":"58","author":"P Workman","year":"1988","unstructured":"Workman, P., Balmain, A., Hickman, J. A., McNally, N. J., Mitchison, N. A., Pierrepoint, C. G., Raymond, R., Rowlatt, C., Stephens, T. C. & Wallace, J. (1988). UKCCCR guidelines for the welfare of animals in experimental neoplasia. Br J Cancer 58: 109\u2013113.","journal-title":"Br J Cancer"},{"key":"BF6690620_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0162-0134(95)00163-8","volume":"63","author":"P Wu","year":"1996","unstructured":"Wu, P., Kharatishvili, M. & Farrell, N. (1996). A circular dichroism study of ethidium bromide binding to Z-DNA induced by dinuclear platinum complexes. J Inorg Biochem 63: 9\u201316.","journal-title":"J Inorg Biochem"},{"key":"BF6690620_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0163-7258(97)00086-7","volume":"76","author":"F Zunino","year":"1997","unstructured":"Zunino, F., Perego, P., Pilotti, S., Pratesi, G., Supino, R. & Arcamone, F. (1997). Role of apoptotic response in cellular resistance to cytotoxic agents. Pharmacol Ther 76: 177\u2013185.","journal-title":"Pharmacol Ther"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690620","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:54:59Z","timestamp":1684414499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7,30]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["BF6690620"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690620","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,7,30]]}}}